<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:595px; height:844px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:58px; top:92px; width:12px; height:11px;"><span style="font-family: Courier; font-size:7px">1558
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:468px; top:93px; width:83px; height:10px;"><span style="font-family: Courier; font-size:7px">Gut, </span><span style="font-family: Courier; font-size:7px">1991, </span><span style="font-family: Courier; font-size:7px">32, </span><span style="font-family: Courier; font-size:7px">1558-1561
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:158px; top:115px; width:319px; height:45px;"><span style="font-family: Courier; font-size:16px">Adenoma of the ampulla of </span><span style="font-family: Courier; font-size:16px">Vater: </span><span style="font-family: Courier; font-size:12px">putative
<br></span><span style="font-family: Courier; font-size:11px">precancerous </span><span style="font-family: Courier; font-size:16px">lesion
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:158px; top:185px; width:99px; height:12px;"><span style="font-family: Courier; font-size:8px">K Yamaguchi, M Enjoji
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:254px; top:234px; width:25px; height:12px;"><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">12
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:289px; top:234px; width:32px; height:12px;"><span style="font-family: Courier; font-size:8px">patients
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:158px; top:224px; width:192px; height:267px;"><span style="font-family: Courier; font-size:8px">Abstract
<br></span><span style="font-family: Courier; font-size:8px">The histopathology
<br></span><span style="font-family: Courier; font-size:8px">with
<br></span><span style="font-family: Courier; font-size:8px">adenoma of the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">examined
<br></span><span style="font-family: Courier; font-size:7px">to </span><span style="font-family: Courier; font-size:7px">trace </span><span style="font-family: Courier; font-size:8px">the adenoma-carcinoma </span><span style="font-family: Courier; font-size:5px">sequence </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater. </span><span style="font-family: Courier; font-size:8px">Immunohistochemistry
<br></span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">carcinoembryonic </span><span style="font-family: Courier; font-size:8px">antigen (CEA) and
<br></span><span style="font-family: Courier; font-size:8px">carbohydrate antigen (CA) </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">also </span><span style="font-family: Courier; font-size:5px">per-
<br></span><span style="font-family: Courier; font-size:8px">formed. Four </span><span style="font-family: Courier; font-size:8px">large </span><span style="font-family: Courier; font-size:8px">adenomas </span><span style="font-family: Courier; font-size:8px">with mild </span><span style="font-family: Courier; font-size:8px">dys-
<br></span><span style="font-family: Courier; font-size:8px">plasia also </span><span style="font-family: Courier; font-size:8px">had foci of </span><span style="font-family: Courier; font-size:8px">moderate dysplasia
<br></span><span style="font-family: Courier; font-size:8px">while another </span><span style="font-family: Courier; font-size:6px">one </span><span style="font-family: Courier; font-size:8px">contained foci </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:6px">severe
<br></span><span style="font-family: Courier; font-size:8px">dysplasia (intramucosal carcinoma). </span><span style="font-family: Courier; font-size:8px">Immuno-
<br></span><span style="font-family: Courier; font-size:8px">histochemicaily, </span><span style="font-family: Courier; font-size:8px">adenomas </span><span style="font-family: Courier; font-size:8px">of mild </span><span style="font-family: Courier; font-size:7px">to </span><span style="font-family: Courier; font-size:8px">moderate
<br>dysplasia </span><span style="font-family: Courier; font-size:8px">had either linear </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and CA19-9
<br></span><span style="font-family: Courier; font-size:8px">immunoreactants </span><span style="font-family: Courier; font-size:7px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">apical </span><span style="font-family: Courier; font-size:8px">portions, </span><span style="font-family: Courier; font-size:5px">or </span><span style="font-family: Courier; font-size:8px">fine
<br></span><span style="font-family: Courier; font-size:8px">granular </span><span style="font-family: Courier; font-size:8px">immunoreactants </span><span style="font-family: Courier; font-size:8px">in the </span><span style="font-family: Courier; font-size:8px">cytoplasm </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">adenoma cells. In </span><span style="font-family: Courier; font-size:8px">addition, </span><span style="font-family: Courier; font-size:8px">adenomas of </span><span style="font-family: Courier; font-size:5px">severe
<br></span><span style="font-family: Courier; font-size:8px">dysplasia (intramucosal carcinoma) </span><span style="font-family: Courier; font-size:8px">showed </span><span style="font-family: Courier; font-size:5px">a
<br></span><span style="font-family: Courier; font-size:5px">more </span><span style="font-family: Courier; font-size:8px">diffuse </span><span style="font-family: Courier; font-size:5px">or </span><span style="font-family: Courier; font-size:8px">dense immunoreactivity </span><span style="font-family: Courier; font-size:8px">for
<br></span><span style="font-family: Courier; font-size:8px">these </span><span style="font-family: Courier; font-size:5px">two </span><span style="font-family: Courier; font-size:8px">substances </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">cytoplasm. </span><span style="font-family: Courier; font-size:8px">These
<br></span><span style="font-family: Courier; font-size:8px">results </span><span style="font-family: Courier; font-size:5px">are </span><span style="font-family: Courier; font-size:8px">consistent </span><span style="font-family: Courier; font-size:8px">with the adenoma-
<br></span><span style="font-family: Courier; font-size:8px">carcinoma </span><span style="font-family: Courier; font-size:6px">sequence </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater.
<br></span><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">immunohistochemistry </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and
<br></span><span style="font-family: Courier; font-size:8px">CA19-9 </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">representative </span><span style="font-family: Courier; font-size:8px">of the </span><span style="font-family: Courier; font-size:8px">degree </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">dysplasia </span><span style="font-family: Courier; font-size:8px">in the adenoma </span><span style="font-family: Courier; font-size:6px">cells, </span><span style="font-family: Courier; font-size:8px">but the </span><span style="font-family: Courier; font-size:8px">relation-
<br></span><span style="font-family: Courier; font-size:8px">ship </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:7px">not </span><span style="font-family: Courier; font-size:8px">conclusive.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:158px; top:510px; width:190px; height:139px;"><span style="font-family: Courier; font-size:8px">Adenoma </span><span style="font-family: Courier; font-size:8px">of the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater is </span><span style="font-family: Courier; font-size:5px">a rare
<br></span><span style="font-family: Courier; font-size:8px">neoplasm' </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:5px">some </span><span style="font-family: Courier; font-size:8px">authors </span><span style="font-family: Courier; font-size:8px">have </span><span style="font-family: Courier; font-size:8px">proposed </span><span style="font-family: Courier; font-size:8px">it </span><span style="font-family: Courier; font-size:6px">to
<br></span><span style="font-family: Courier; font-size:8px">be </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">premalignant </span><span style="font-family: Courier; font-size:8px">lesion.23 </span><span style="font-family: Courier; font-size:8px">However, </span><span style="font-family: Courier; font-size:6px">most </span><span style="font-family: Courier; font-size:8px">of the
<br></span><span style="font-family: Courier; font-size:5px">papers </span><span style="font-family: Courier; font-size:5px">were case </span><span style="font-family: Courier; font-size:6px">reports </span><span style="font-family: Courier; font-size:8px">and there has been </span><span style="font-family: Courier; font-size:5px">no
<br></span><span style="font-family: Courier; font-size:8px">study </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">large </span><span style="font-family: Courier; font-size:8px">number </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:5px">cases </span><span style="font-family: Courier; font-size:8px">of the lesion.
<br></span><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:6px">exact </span><span style="font-family: Courier; font-size:8px">clinicopathology </span><span style="font-family: Courier; font-size:8px">of this disease has
<br></span><span style="font-family: Courier; font-size:8px">also been described </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">detail </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">only </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">few
<br></span><span style="font-family: Courier; font-size:6px">reports. </span><span style="font-family: Courier; font-size:8px">We have </span><span style="font-family: Courier; font-size:8px">reported </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">clinicopathology
<br></span><span style="font-family: Courier; font-size:8px">of 114 </span><span style="font-family: Courier; font-size:5px">cases </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">neoplasms </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater,
<br></span><span style="font-family: Courier; font-size:8px">mainly </span><span style="font-family: Courier; font-size:5px">carcinoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater.4 </span><span style="font-family: Courier; font-size:8px">In the
<br></span><span style="font-family: Courier; font-size:6px">report </span><span style="font-family: Courier; font-size:5px">we </span><span style="font-family: Courier; font-size:8px">briefly </span><span style="font-family: Courier; font-size:8px">described </span><span style="font-family: Courier; font-size:8px">five </span><span style="font-family: Courier; font-size:6px">cases </span><span style="font-family: Courier; font-size:8px">of adenoma
<br></span><span style="font-family: Courier; font-size:8px">of the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater. Since </span><span style="font-family: Courier; font-size:5px">we </span><span style="font-family: Courier; font-size:8px">experienced </span><span style="font-family: Courier; font-size:5px">an
<br></span><span style="font-family: Courier; font-size:8px">additional </span><span style="font-family: Courier; font-size:6px">seven </span><span style="font-family: Courier; font-size:5px">cases </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">lesions, </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">clinico-
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:362px; top:223px; width:192px; height:75px;"><span style="font-family: Courier; font-size:8px">pathology </span><span style="font-family: Courier; font-size:8px">of 12 </span><span style="font-family: Courier; font-size:5px">cases </span><span style="font-family: Courier; font-size:8px">of adenoma </span><span style="font-family: Courier; font-size:8px">of ampulla of
<br></span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">will </span><span style="font-family: Courier; font-size:8px">be </span><span style="font-family: Courier; font-size:8px">reported </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">detail </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">order </span><span style="font-family: Courier; font-size:6px">to trace
<br></span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">progressive changes </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:5px">precancerous </span><span style="font-family: Courier; font-size:8px">dys-
<br></span><span style="font-family: Courier; font-size:8px">plasia </span><span style="font-family: Courier; font-size:8px">of this lesion. Immunohistochemistry </span><span style="font-family: Courier; font-size:8px">for
<br></span><span style="font-family: Courier; font-size:8px">carcinoembryonic antigen (CEA) </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">carbo-
<br></span><span style="font-family: Courier; font-size:8px">hydrate antigen (CA) </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">also </span><span style="font-family: Courier; font-size:8px">applied </span><span style="font-family: Courier; font-size:6px">to
<br></span><span style="font-family: Courier; font-size:8px">this </span><span style="font-family: Courier; font-size:8px">study.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:362px; top:319px; width:191px; height:118px;"><span style="font-family: Courier; font-size:8px">Materials </span><span style="font-family: Courier; font-size:8px">and methods
<br></span><span style="font-family: Courier; font-size:8px">A </span><span style="font-family: Courier; font-size:8px">total of 12 </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">with adenoma </span><span style="font-family: Courier; font-size:8px">of the
<br></span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of Vater </span><span style="font-family: Courier; font-size:6px">were </span><span style="font-family: Courier; font-size:8px">selected from </span><span style="font-family: Courier; font-size:5px">more </span><span style="font-family: Courier; font-size:8px">than
<br></span><span style="font-family: Courier; font-size:8px">400 </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">pancreatoduodenal </span><span style="font-family: Courier; font-size:8px">tumours,`7
<br></span><span style="font-family: Courier; font-size:8px">which </span><span style="font-family: Courier; font-size:5px">were </span><span style="font-family: Courier; font-size:8px">examined </span><span style="font-family: Courier; font-size:8px">in 5 </span><span style="font-family: Courier; font-size:5px">mm </span><span style="font-family: Courier; font-size:6px">stepwise tissue
<br></span><span style="font-family: Courier; font-size:8px">sections. </span><span style="font-family: Courier; font-size:8px">All </span><span style="font-family: Courier; font-size:8px">the tissue sections </span><span style="font-family: Courier; font-size:6px">were </span><span style="font-family: Courier; font-size:8px">stained </span><span style="font-family: Courier; font-size:8px">with
<br></span><span style="font-family: Courier; font-size:8px">haematoxylin and eosin and </span><span style="font-family: Courier; font-size:5px">some </span><span style="font-family: Courier; font-size:8px">representative
<br>tissue </span><span style="font-family: Courier; font-size:8px">sections </span><span style="font-family: Courier; font-size:5px">were </span><span style="font-family: Courier; font-size:8px">also stained </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">periodic
<br></span><span style="font-family: Courier; font-size:8px">acid </span><span style="font-family: Courier; font-size:8px">Schiff, </span><span style="font-family: Courier; font-size:8px">alcian blue </span><span style="font-family: Courier; font-size:8px">pH 2-5, </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">by </span><span style="font-family: Courier; font-size:8px">Grimelius'
<br></span><span style="font-family: Courier; font-size:8px">procedure. </span><span style="font-family: Courier; font-size:8px">They </span><span style="font-family: Courier; font-size:5px">were </span><span style="font-family: Courier; font-size:8px">submitted </span><span style="font-family: Courier; font-size:6px">to </span><span style="font-family: Courier; font-size:8px">immuno-
<br>histochemistry </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA </span><span style="font-family: Courier; font-size:8px">19-9.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:362px; top:436px; width:191px; height:214px;"><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">primary antibody </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">polyclonal
<br></span><span style="font-family: Courier; font-size:8px">rabbit </span><span style="font-family: Courier; font-size:8px">antibody, </span><span style="font-family: Courier; font-size:8px">which </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">obtained from
<br></span><span style="font-family: Courier; font-size:8px">Zymed </span><span style="font-family: Courier; font-size:8px">Laboratories </span><span style="font-family: Courier; font-size:8px">Inc, </span><span style="font-family: Courier; font-size:8px">San </span><span style="font-family: Courier; font-size:8px">Francisco, </span><span style="font-family: Courier; font-size:8px">and
<br></span><span style="font-family: Courier; font-size:8px">generated </span><span style="font-family: Courier; font-size:8px">against highly purified </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">isolated
<br>from </span><span style="font-family: Courier; font-size:8px">liver metastasis </span><span style="font-family: Courier; font-size:8px">of colon </span><span style="font-family: Courier; font-size:8px">adenocarcinoma.
<br></span><span style="font-family: Courier; font-size:8px">Non-specific </span><span style="font-family: Courier; font-size:8px">antibodies </span><span style="font-family: Courier; font-size:5px">were </span><span style="font-family: Courier; font-size:8px">removed </span><span style="font-family: Courier; font-size:8px">by </span><span style="font-family: Courier; font-size:8px">solid-
<br></span><span style="font-family: Courier; font-size:8px">phase immunoabsorption </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">normal human
<br></span><span style="font-family: Courier; font-size:8px">plasma </span><span style="font-family: Courier; font-size:8px">and human red </span><span style="font-family: Courier; font-size:8px">blood </span><span style="font-family: Courier; font-size:8px">cells. Immuno-
<br></span><span style="font-family: Courier; font-size:8px">electrophoresis </span><span style="font-family: Courier; font-size:8px">of the absorbed antiserum </span><span style="font-family: Courier; font-size:8px">against
<br></span><span style="font-family: Courier; font-size:8px">parietal </span><span style="font-family: Courier; font-size:8px">cell </span><span style="font-family: Courier; font-size:8px">antibody </span><span style="font-family: Courier; font-size:6px">extract </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:6px">tumour </span><span style="font-family: Courier; font-size:8px">tissue
<br></span><span style="font-family: Courier; font-size:8px">showed </span><span style="font-family: Courier; font-size:8px">only </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">single precipitation </span><span style="font-family: Courier; font-size:5px">arc. </span><span style="font-family: Courier; font-size:8px">CA </span><span style="font-family: Courier; font-size:8px">19-9
<br></span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:6px">a </span><span style="font-family: Courier; font-size:8px">monoclonal </span><span style="font-family: Courier; font-size:6px">mouse </span><span style="font-family: Courier; font-size:8px">antibody and </span><span style="font-family: Courier; font-size:5px">was
<br></span><span style="font-family: Courier; font-size:8px">obtained from </span><span style="font-family: Courier; font-size:8px">Toray Fuji </span><span style="font-family: Courier; font-size:8px">Bionics, </span><span style="font-family: Courier; font-size:8px">Tokyo. </span><span style="font-family: Courier; font-size:8px">The
<br></span><span style="font-family: Courier; font-size:8px">antibody (1 </span><span style="font-family: Courier; font-size:8px">116 </span><span style="font-family: Courier; font-size:8px">NS </span><span style="font-family: Courier; font-size:8px">19-9) </span><span style="font-family: Courier; font-size:5px">was </span><span style="font-family: Courier; font-size:8px">generated </span><span style="font-family: Courier; font-size:8px">against </span><span style="font-family: Courier; font-size:5px">a
<br></span><span style="font-family: Courier; font-size:8px">human </span><span style="font-family: Courier; font-size:8px">colorectal carcinoma cell line </span><span style="font-family: Courier; font-size:8px">(SW 1116)
<br></span><span style="font-family: Courier; font-size:8px">by </span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:8px">hybridoma technique. </span><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">avidin-biotin-
<br></span><span style="font-family: Courier; font-size:8px">peroxidase </span><span style="font-family: Courier; font-size:8px">complex </span><span style="font-family: Courier; font-size:8px">method </span><span style="font-family: Courier; font-size:6px">was </span><span style="font-family: Courier; font-size:8px">used </span><span style="font-family: Courier; font-size:8px">and the
<br>avidin </span><span style="font-family: Courier; font-size:8px">and biotin </span><span style="font-family: Courier; font-size:6px">reagents </span><span style="font-family: Courier; font-size:5px">were </span><span style="font-family: Courier; font-size:8px">obtained from
<br></span><span style="font-family: Courier; font-size:8px">Vector </span><span style="font-family: Courier; font-size:8px">Laboratories, Burlingame, </span><span style="font-family: Courier; font-size:8px">California
<br></span><span style="font-family: Courier; font-size:8px">(Vectastain </span><span style="font-family: Courier; font-size:8px">ABC </span><span style="font-family: Courier; font-size:8px">kits, </span><span style="font-family: Courier; font-size:8px">PK-4001 </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">PK-4002).
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:159px; top:676px; width:251px; height:11px;"><span style="font-family: Courier; font-size:8px">Clinicopathologicalfindings </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">12 </span><span style="font-family: Courier; font-size:7px">patients </span><span style="font-family: Courier; font-size:7px">with adenoma </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">the </span><span style="font-family: Courier; font-size:7px">ampulla </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">Vater
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:159px; top:708px; width:16px; height:107px;"><span style="font-family: Courier; font-size:6px">No </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:6px">cases
<br></span><span style="font-family: Courier; font-size:6px">it
<br></span><span style="font-family: Courier; font-size:6px">2
<br></span><span style="font-family: Courier; font-size:6px">3
<br></span><span style="font-family: Courier; font-size:6px">4
<br></span><span style="font-family: Courier; font-size:6px">5
<br></span><span style="font-family: Courier; font-size:6px">6
<br>7
<br></span><span style="font-family: Courier; font-size:6px">8
<br></span><span style="font-family: Courier; font-size:6px">9t
<br></span><span style="font-family: Courier; font-size:7px">lot
<br></span><span style="font-family: Courier; font-size:6px">11
<br>12
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:192px; top:708px; width:18px; height:16px;"><span style="font-family: Courier; font-size:6px">Age
<br></span><span style="font-family: Courier; font-size:6px">(years)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:220px; top:708px; width:10px; height:9px;"><span style="font-family: Courier; font-size:6px">Sex
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:192px; top:730px; width:6px; height:85px;"><span style="font-family: Courier; font-size:6px">57
<br></span><span style="font-family: Courier; font-size:6px">72
<br></span><span style="font-family: Courier; font-size:6px">70
<br>51
<br></span><span style="font-family: Courier; font-size:6px">48
<br></span><span style="font-family: Courier; font-size:6px">48
<br></span><span style="font-family: Courier; font-size:6px">50
<br></span><span style="font-family: Courier; font-size:6px">69
<br></span><span style="font-family: Courier; font-size:6px">64
<br></span><span style="font-family: Courier; font-size:6px">63
<br>71
<br></span><span style="font-family: Courier; font-size:6px">58
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:220px; top:730px; width:6px; height:85px;"><span style="font-family: Courier; font-size:6px">F
<br></span><span style="font-family: Courier; font-size:6px">M
<br></span><span style="font-family: Courier; font-size:6px">F
<br></span><span style="font-family: Courier; font-size:6px">F
<br></span><span style="font-family: Courier; font-size:6px">M
<br>M
<br></span><span style="font-family: Courier; font-size:6px">F
<br></span><span style="font-family: Courier; font-size:6px">M
<br></span><span style="font-family: Courier; font-size:6px">M
<br></span><span style="font-family: Courier; font-size:6px">F
<br></span><span style="font-family: Courier; font-size:6px">M
<br>M
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:248px; top:708px; width:46px; height:107px;"><span style="font-family: Courier; font-size:6px">Chief
<br>complaints
<br></span><span style="font-family: Courier; font-size:6px">Abdominal </span><span style="font-family: Courier; font-size:6px">pain
<br></span><span style="font-family: Courier; font-size:6px">t
<br></span><span style="font-family: Courier; font-size:6px">Icterus
<br>Abdominal </span><span style="font-family: Courier; font-size:6px">pain
<br></span><span style="font-family: Courier; font-size:6px">Abdominal </span><span style="font-family: Courier; font-size:6px">pain
<br></span><span style="font-family: Courier; font-size:6px">t
<br></span><span style="font-family: Courier; font-size:6px">t
<br></span><span style="font-family: Courier; font-size:6px">Abdominal </span><span style="font-family: Courier; font-size:6px">pain
<br></span><span style="font-family: Courier; font-size:6px">Abdominal </span><span style="font-family: Courier; font-size:6px">pain
<br></span><span style="font-family: Courier; font-size:6px">Fever
<br></span><span style="font-family: Courier; font-size:6px">Icterus
<br></span><span style="font-family: Courier; font-size:6px">Icterus
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:312px; top:701px; width:23px; height:113px;"><span style="font-family: Courier; font-size:6px">Greatest
<br></span><span style="font-family: Courier; font-size:6px">diameter
<br></span><span style="font-family: Courier; font-size:6px">(cm)
<br></span><span style="font-family: Courier; font-size:6px">2-5
<br></span><span style="font-family: Courier; font-size:6px">2-2
<br></span><span style="font-family: Courier; font-size:6px">1 </span><span style="font-family: Courier; font-size:6px">5
<br>1.5
<br></span><span style="font-family: Courier; font-size:6px">2-0
<br></span><span style="font-family: Courier; font-size:6px">3.0
<br></span><span style="font-family: Courier; font-size:6px">3.0
<br></span><span style="font-family: Courier; font-size:6px">3.0
<br>3.0
<br></span><span style="font-family: Courier; font-size:6px">3.0
<br></span><span style="font-family: Courier; font-size:6px">3.5
<br>2.5
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:355px; top:708px; width:34px; height:16px;"><span style="font-family: Courier; font-size:6px">Macroscopic
<br></span><span style="font-family: Courier; font-size:6px">type
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:356px; top:729px; width:8px; height:85px;"><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">IP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span><span style="font-family: Courier; font-size:6px">IP
<br>EP
<br>EP
<br></span><span style="font-family: Courier; font-size:6px">EP
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:477px; top:694px; width:29px; height:30px;"><span style="font-family: Courier; font-size:6px">Prognosis
<br></span><span style="font-family: Courier; font-size:6px">Follow-up
<br>(months)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:477px; top:729px; width:6px; height:85px;"><span style="font-family: Courier; font-size:6px">30
<br></span><span style="font-family: Courier; font-size:6px">34
<br></span><span style="font-family: Courier; font-size:6px">52
<br></span><span style="font-family: Courier; font-size:6px">88
<br></span><span style="font-family: Courier; font-size:6px">96
<br></span><span style="font-family: Courier; font-size:6px">8
<br></span><span style="font-family: Courier; font-size:6px">2
<br></span><span style="font-family: Courier; font-size:6px">40
<br>17
<br></span><span style="font-family: Courier; font-size:6px">21
<br>87
<br></span><span style="font-family: Courier; font-size:6px">32
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:410px; top:715px; width:61px; height:100px;"><span style="font-family: Courier; font-size:6px">Atypia
<br></span><span style="font-family: Courier; font-size:6px">Mild
<br>Mild
<br></span><span style="font-family: Courier; font-size:6px">Mild
<br>Mild
<br></span><span style="font-family: Courier; font-size:6px">Mild
<br></span><span style="font-family: Courier; font-size:6px">Mild
<br></span><span style="font-family: Courier; font-size:6px">Mild
<br></span><span style="font-family: Courier; font-size:6px">Moderate
<br></span><span style="font-family: Courier; font-size:6px">Moderate
<br></span><span style="font-family: Courier; font-size:6px">Moderate
<br></span><span style="font-family: Courier; font-size:6px">Moderate
<br></span><span style="font-family: Courier; font-size:6px">Severe </span><span style="font-family: Courier; font-size:6px">(intramucosal
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:417px; top:813px; width:32px; height:9px;"><span style="font-family: Courier; font-size:6px">carcinoma)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:525px; top:715px; width:24px; height:9px;"><span style="font-family: Courier; font-size:6px">Outcome
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:525px; top:729px; width:14px; height:85px;"><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br>Well
<br>Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Died
<br>Died
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span><span style="font-family: Courier; font-size:6px">Well
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:159px; top:830px; width:269px; height:29px;"><span style="font-family: Courier; font-size:6px">IP=intramural </span><span style="font-family: Courier; font-size:6px">protruding form; </span><span style="font-family: Courier; font-size:6px">EP=exposed </span><span style="font-family: Courier; font-size:6px">protruding </span><span style="font-family: Courier; font-size:6px">form.
<br>*Associated </span><span style="font-family: Courier; font-size:6px">with </span><span style="font-family: Courier; font-size:6px">early gastric </span><span style="font-family: Courier; font-size:6px">carcinoma.
<br></span><span style="font-family: Courier; font-size:6px">tA polypoid </span><span style="font-family: Courier; font-size:6px">tumour </span><span style="font-family: Courier; font-size:6px">of the </span><span style="font-family: Courier; font-size:6px">ampulla </span><span style="font-family: Courier; font-size:6px">of Vater was incidentally found </span><span style="font-family: Courier; font-size:6px">by </span><span style="font-family: Courier; font-size:6px">gastrointestinal </span><span style="font-family: Courier; font-size:6px">series.
<br></span><span style="font-family: Courier; font-size:6px">tTwo patients (cases 9 and 10) died from </span><span style="font-family: Courier; font-size:6px">cardiac </span><span style="font-family: Courier; font-size:6px">failure, </span><span style="font-family: Courier; font-size:6px">not associated with metastasis.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:744px; width:88px; height:114px;"><span style="font-family: Courier; font-size:6px">Second </span><span style="font-family: Courier; font-size:7px">Department </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:7px">Pathology </span><span style="font-family: Courier; font-size:6px">and the </span><span style="font-family: Courier; font-size:6px">First
<br></span><span style="font-family: Courier; font-size:7px">Department </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:7px">Surgery,
<br></span><span style="font-family: Courier; font-size:7px">Faculty </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:7px">Medicine,
<br></span><span style="font-family: Courier; font-size:7px">Kyushu University,
<br></span><span style="font-family: Courier; font-size:6px">3-1-1 </span><span style="font-family: Courier; font-size:7px">Maidashi,
<br></span><span style="font-family: Courier; font-size:7px">Higashi-ku, </span><span style="font-family: Courier; font-size:6px">Fukuoka </span><span style="font-family: Courier; font-size:7px">812,
<br></span><span style="font-family: Courier; font-size:5px">Japan
<br></span><span style="font-family: Courier; font-size:6px">K </span><span style="font-family: Courier; font-size:7px">Yamaguchi
<br></span><span style="font-family: Courier; font-size:6px">M </span><span style="font-family: Courier; font-size:7px">Enjoji
<br></span><span style="font-family: Courier; font-size:6px">Correspondence </span><span style="font-family: Courier; font-size:4px">to:
<br></span><span style="font-family: Courier; font-size:6px">Koji </span><span style="font-family: Courier; font-size:6px">Yamaguchi.
<br></span><span style="font-family: Courier; font-size:6px">Accepted </span><span style="font-family: Courier; font-size:5px">for </span><span style="font-family: Courier; font-size:6px">publication
<br></span><span style="font-family: Courier; font-size:5px">11 </span><span style="font-family: Courier; font-size:6px">February </span><span style="font-family: Courier; font-size:5px">1991
<br></span></div><span style="position:absolute; border: gray 1px solid; left:0px; top:944px; width:595px; height:844px;"></span>
<div style="position:absolute; top:944px;"><a name="2">Page 2</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:44px; top:988px; width:192px; height:10px;"><span style="font-family: Courier; font-size:7px">Adenoma </span><span style="font-family: Courier; font-size:7px">ofthe ampulla </span><span style="font-family: Courier; font-size:7px">of Vater: </span><span style="font-family: Courier; font-size:7px">putative </span><span style="font-family: Courier; font-size:7px">precancerous lesion
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:529px; top:988px; width:14px; height:10px;"><span style="font-family: Courier; font-size:7px">1559
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:1012px; width:192px; height:97px;"><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">localisation of </span><span style="font-family: Courier; font-size:8px">antigens </span><span style="font-family: Courier; font-size:8px">was </span><span style="font-family: Courier; font-size:8px">visualised </span><span style="font-family: Courier; font-size:8px">by
<br></span><span style="font-family: Courier; font-size:8px">placing the slides </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">0.01% </span><span style="font-family: Courier; font-size:8px">hydrogen </span><span style="font-family: Courier; font-size:8px">peroxide
<br></span><span style="font-family: Courier; font-size:8px">and 0.05% </span><span style="font-family: Courier; font-size:8px">diaminobenzidine </span><span style="font-family: Courier; font-size:8px">in 0.05 </span><span style="font-family: Courier; font-size:8px">M </span><span style="font-family: Courier; font-size:8px">phos-
<br>phate </span><span style="font-family: Courier; font-size:9px">saline </span><span style="font-family: Courier; font-size:8px">buffer, pH 7.2, </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">five </span><span style="font-family: Courier; font-size:8px">minutes. All
<br>sections </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">counterstained with methyl green.
<br></span><span style="font-family: Courier; font-size:8px">Clinical </span><span style="font-family: Courier; font-size:8px">charts </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">available </span><span style="font-family: Courier; font-size:8px">from </span><span style="font-family: Courier; font-size:8px">all </span><span style="font-family: Courier; font-size:8px">12
<br></span><span style="font-family: Courier; font-size:8px">patients. </span><span style="font-family: Courier; font-size:8px">Follow up </span><span style="font-family: Courier; font-size:8px">information </span><span style="font-family: Courier; font-size:8px">was </span><span style="font-family: Courier; font-size:8px">obtainable
<br></span><span style="font-family: Courier; font-size:8px">from </span><span style="font-family: Courier; font-size:8px">all </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">and were </span><span style="font-family: Courier; font-size:8px">up-dated </span><span style="font-family: Courier; font-size:8px">on </span><span style="font-family: Courier; font-size:8px">June
<br></span><span style="font-family: Courier; font-size:8px">30, </span><span style="font-family: Courier; font-size:8px">1990.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:1129px; width:30px; height:12px;"><span style="font-family: Courier; font-size:8px">Results
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:1153px; width:193px; height:189px;"><span style="font-family: Courier; font-size:6px">CLINICAL FINDINGS
<br></span><span style="font-family: Courier; font-size:8px">The total </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">with adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">ampulla
<br></span><span style="font-family: Courier; font-size:9px">of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:9px">ranged from </span><span style="font-family: Courier; font-size:8px">48 to 72 </span><span style="font-family: Courier; font-size:8px">years </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">age </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">a
<br></span><span style="font-family: Courier; font-size:8px">mean </span><span style="font-family: Courier; font-size:9px">of </span><span style="font-family: Courier; font-size:9px">59.7 </span><span style="font-family: Courier; font-size:8px">years </span><span style="font-family: Courier; font-size:9px">(Table). </span><span style="font-family: Courier; font-size:9px">The </span><span style="font-family: Courier; font-size:9px">patients </span><span style="font-family: Courier; font-size:8px">con-
<br></span><span style="font-family: Courier; font-size:8px">sisted </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">seven </span><span style="font-family: Courier; font-size:8px">men </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">five </span><span style="font-family: Courier; font-size:8px">women, </span><span style="font-family: Courier; font-size:9px">showing </span><span style="font-family: Courier; font-size:8px">a
<br></span><span style="font-family: Courier; font-size:8px">male </span><span style="font-family: Courier; font-size:9px">predominance </span><span style="font-family: Courier; font-size:9px">of </span><span style="font-family: Courier; font-size:8px">1.4. </span><span style="font-family: Courier; font-size:8px">Three </span><span style="font-family: Courier; font-size:9px">developed
<br></span><span style="font-family: Courier; font-size:8px">icterus </span><span style="font-family: Courier; font-size:8px">due </span><span style="font-family: Courier; font-size:8px">to an obstruction of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">bile </span><span style="font-family: Courier; font-size:8px">duct </span><span style="font-family: Courier; font-size:9px">by
<br></span><span style="font-family: Courier; font-size:8px">adenoma. Six </span><span style="font-family: Courier; font-size:9px">patients </span><span style="font-family: Courier; font-size:9px">complained </span><span style="font-family: Courier; font-size:8px">of abdominal
<br></span><span style="font-family: Courier; font-size:9px">pain </span><span style="font-family: Courier; font-size:8px">and/or </span><span style="font-family: Courier; font-size:8px">fever </span><span style="font-family: Courier; font-size:9px">probably </span><span style="font-family: Courier; font-size:8px">caused </span><span style="font-family: Courier; font-size:9px">by </span><span style="font-family: Courier; font-size:8px">cholan-
<br></span><span style="font-family: Courier; font-size:8px">gitis. </span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:8px">the other </span><span style="font-family: Courier; font-size:8px">three </span><span style="font-family: Courier; font-size:9px">patients </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:9px">polypoid
<br></span><span style="font-family: Courier; font-size:8px">tumour </span><span style="font-family: Courier; font-size:9px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:9px">ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater was </span><span style="font-family: Courier; font-size:9px">incidentally
<br></span><span style="font-family: Courier; font-size:8px">found </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">upper </span><span style="font-family: Courier; font-size:9px">gastrointestinal </span><span style="font-family: Courier; font-size:8px">series. </span><span style="font-family: Courier; font-size:9px">Preopera-
<br></span><span style="font-family: Courier; font-size:8px">tive </span><span style="font-family: Courier; font-size:8px">serum </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA19-9 levels </span><span style="font-family: Courier; font-size:8px">were
<br></span><span style="font-family: Courier; font-size:8px">examined </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">five </span><span style="font-family: Courier; font-size:8px">and three </span><span style="font-family: Courier; font-size:9px">patients, </span><span style="font-family: Courier; font-size:9px">respectively.
<br></span><span style="font-family: Courier; font-size:8px">All </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">within </span><span style="font-family: Courier; font-size:8px">normal </span><span style="font-family: Courier; font-size:8px">limits. </span><span style="font-family: Courier; font-size:8px">Nine </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">12
<br></span><span style="font-family: Courier; font-size:9px">patients </span><span style="font-family: Courier; font-size:8px">had </span><span style="font-family: Courier; font-size:9px">previously </span><span style="font-family: Courier; font-size:9px">undergone </span><span style="font-family: Courier; font-size:8px">pancreato-
<br></span><span style="font-family: Courier; font-size:9px">duodenectomy </span><span style="font-family: Courier; font-size:8px">and the </span><span style="font-family: Courier; font-size:9px">remaining </span><span style="font-family: Courier; font-size:8px">three </span><span style="font-family: Courier; font-size:8px">had
<br></span><span style="font-family: Courier; font-size:9px">received </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">transduodenal </span><span style="font-family: Courier; font-size:9px">papillectomy.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:353px; top:1364px; width:192px; height:62px;"><span style="font-family: Courier; font-size:6px">MACROSCOPIC </span><span style="font-family: Courier; font-size:6px">FINDINGS
<br></span><span style="font-family: Courier; font-size:8px">All </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">tumours </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:9px">protruding </span><span style="font-family: Courier; font-size:8px">type </span><span style="font-family: Courier; font-size:8px">and
<br></span><span style="font-family: Courier; font-size:8px">consisted </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">two </span><span style="font-family: Courier; font-size:8px">intramural </span><span style="font-family: Courier; font-size:8px">types </span><span style="font-family: Courier; font-size:9px">(Figs </span><span style="font-family: Courier; font-size:8px">1 </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">2)
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">10 </span><span style="font-family: Courier; font-size:8px">exposed </span><span style="font-family: Courier; font-size:8px">types </span><span style="font-family: Courier; font-size:9px">(Figs </span><span style="font-family: Courier; font-size:8px">3 and </span><span style="font-family: Courier; font-size:8px">4). </span><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">12
<br></span><span style="font-family: Courier; font-size:8px">tumours </span><span style="font-family: Courier; font-size:9px">ranged </span><span style="font-family: Courier; font-size:8px">from </span><span style="font-family: Courier; font-size:8px">1.5 </span><span style="font-family: Courier; font-size:8px">to </span><span style="font-family: Courier; font-size:8px">3.5 </span><span style="font-family: Courier; font-size:8px">cm </span><span style="font-family: Courier; font-size:8px">in the
<br></span><span style="font-family: Courier; font-size:8px">greatest </span><span style="font-family: Courier; font-size:8px">diameter </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">a mean </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">2 </span><span style="font-family: Courier; font-size:8px">6 </span><span style="font-family: Courier; font-size:8px">cm.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:353px; top:1448px; width:192px; height:94px;"><span style="font-family: Courier; font-size:6px">MICROSCOPIC </span><span style="font-family: Courier; font-size:6px">FINDINGS
<br></span><span style="font-family: Courier; font-size:8px">All </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">tumours </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">composed of </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:9px">papillary </span><span style="font-family: Courier; font-size:8px">or
<br></span><span style="font-family: Courier; font-size:8px">tubular </span><span style="font-family: Courier; font-size:9px">proliferation </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:9px">atypical </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:9px">(Fig 5).
<br>They </span><span style="font-family: Courier; font-size:8px">had tall </span><span style="font-family: Courier; font-size:8px">or </span><span style="font-family: Courier; font-size:8px">columnar </span><span style="font-family: Courier; font-size:9px">epithelia </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">an
<br></span><span style="font-family: Courier; font-size:8px">or </span><span style="font-family: Courier; font-size:8px">clear </span><span style="font-family: Courier; font-size:9px">cytoplasm, containing
<br></span><span style="font-family: Courier; font-size:9px">eosinophilic
<br></span><span style="font-family: Courier; font-size:8px">goblet </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">cases, </span><span style="font-family: Courier; font-size:9px">argentaffin </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">11 </span><span style="font-family: Courier; font-size:8px">and
<br></span><span style="font-family: Courier; font-size:8px">Paneth </span><span style="font-family: Courier; font-size:8px">cells in </span><span style="font-family: Courier; font-size:9px">eight (Fig </span><span style="font-family: Courier; font-size:8px">6). </span><span style="font-family: Courier; font-size:8px">Incomplete </span><span style="font-family: Courier; font-size:8px">or
<br></span><span style="font-family: Courier; font-size:9px">complete </span><span style="font-family: Courier; font-size:8px">brush </span><span style="font-family: Courier; font-size:8px">borders </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">seen </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">line </span><span style="font-family: Courier; font-size:8px">along
<br></span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">luminal </span><span style="font-family: Courier; font-size:8px">surface </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">atypical </span><span style="font-family: Courier; font-size:8px">tubules </span><span style="font-family: Courier; font-size:8px">or </span><span style="font-family: Courier; font-size:8px">glands
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:73px; top:1213px; width:7px; height:13px;"><span style="font-family: Courier; font-size:9px">15
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:100px; top:1213px; width:8px; height:12px;"><span style="font-family: Courier; font-size:9px">16
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:236px; top:1199px; width:9px; height:27px;"><span style="font-family: Courier; font-size:8px">I
<br></span><span style="font-family: Courier; font-size:10px">21
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:262px; top:1198px; width:24px; height:28px;"><span style="font-family: Courier; font-size:9px">1 1 </span><span style="font-family: Courier; font-size:9px">1
<br></span><span style="font-family: Courier; font-size:8px">2?
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:288px; top:1198px; width:11px; height:28px;"><span style="font-family: Courier; font-size:9px">1
<br></span><span style="font-family: Courier; font-size:8px">23
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:316px; top:1213px; width:11px; height:12px;"><span style="font-family: Courier; font-size:8px">24
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:45px; top:1231px; width:271px; height:19px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">1: </span><span style="font-family: Courier; font-size:7px">Intramural </span><span style="font-family: Courier; font-size:7px">protruding </span><span style="font-family: Courier; font-size:7px">type. </span><span style="font-family: Courier; font-size:7px">Enlarged </span><span style="font-family: Courier; font-size:7px">ampulla of </span><span style="font-family: Courier; font-size:7px">Vater </span><span style="font-family: Courier; font-size:7px">is </span><span style="font-family: Courier; font-size:7px">covered by </span><span style="font-family: Courier; font-size:7px">normal
<br></span><span style="font-family: Courier; font-size:7px">duodenal </span><span style="font-family: Courier; font-size:6px">mucosa. </span><span style="font-family: Courier; font-size:7px">Scale </span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:6px">cm.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:148px; top:1397px; width:191px; height:34px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">2: </span><span style="font-family: Courier; font-size:7px">Intramural </span><span style="font-family: Courier; font-size:7px">protruding </span><span style="font-family: Courier; font-size:7px">type, </span><span style="font-family: Courier; font-size:7px">papillary </span><span style="font-family: Courier; font-size:7px">adenoma.
<br></span><span style="font-family: Courier; font-size:7px">Papillary proliferation </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">atypical cells </span><span style="font-family: Courier; font-size:7px">mainly in the </span><span style="font-family: Courier; font-size:7px">common
<br></span><span style="font-family: Courier; font-size:7px">channel, </span><span style="font-family: Courier; font-size:7px">the bile </span><span style="font-family: Courier; font-size:7px">duct </span><span style="font-family: Courier; font-size:7px">and </span><span style="font-family: Courier; font-size:7px">partly in </span><span style="font-family: Courier; font-size:7px">the pancreatic duct.
<br></span><span style="font-family: Courier; font-size:7px">(Haematoxylin </span><span style="font-family: Courier; font-size:7px">and eosin, </span><span style="font-family: Courier; font-size:7px">original </span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:7px">x4.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:148px; top:1581px; width:176px; height:19px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">3: </span><span style="font-family: Courier; font-size:7px">Exposed protruding </span><span style="font-family: Courier; font-size:7px">type. Exposed </span><span style="font-family: Courier; font-size:7px">adenoma </span><span style="font-family: Courier; font-size:7px">is
<br></span><span style="font-family: Courier; font-size:7px">lobulated </span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:7px">surface.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:45px; top:1685px; width:90px; height:65px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">4: </span><span style="font-family: Courier; font-size:7px">Exposed
<br></span><span style="font-family: Courier; font-size:7px">protruding </span><span style="font-family: Courier; font-size:7px">type,
<br></span><span style="font-family: Courier; font-size:7px">papillotubular </span><span style="font-family: Courier; font-size:7px">adenoma.
<br></span><span style="font-family: Courier; font-size:7px">Papillary </span><span style="font-family: Courier; font-size:7px">or </span><span style="font-family: Courier; font-size:7px">tubular
<br></span><span style="font-family: Courier; font-size:6px">structures </span><span style="font-family: Courier; font-size:7px">ofatypical </span><span style="font-family: Courier; font-size:7px">cells, </span><span style="font-family: Courier; font-size:6px">as
<br></span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">2. </span><span style="font-family: Courier; font-size:7px">(Haematoxylin
<br></span><span style="font-family: Courier; font-size:7px">and </span><span style="font-family: Courier; font-size:7px">eosin, original
<br></span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:8px">x4.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:353px; top:1724px; width:193px; height:26px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">5: Tubular </span><span style="font-family: Courier; font-size:7px">adenoma, </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:7px">atypical </span><span style="font-family: Courier; font-size:7px">tubules </span><span style="font-family: Courier; font-size:7px">containing
<br></span><span style="font-family: Courier; font-size:7px">goblet </span><span style="font-family: Courier; font-size:7px">cells. </span><span style="font-family: Courier; font-size:7px">(Haematoxylin </span><span style="font-family: Courier; font-size:7px">and eosin, </span><span style="font-family: Courier; font-size:7px">original </span><span style="font-family: Courier; font-size:7px">magnification
<br></span><span style="font-family: Courier; font-size:7px">x60.)
<br></span></div><span style="position:absolute; border: gray 1px solid; left:0px; top:1839px; width:595px; height:844px;"></span>
<div style="position:absolute; top:1839px;"><a name="3">Page 3</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:54px; top:1881px; width:14px; height:10px;"><span style="font-family: Courier; font-size:7px">1560
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:494px; top:1881px; width:59px; height:12px;"><span style="font-family: Courier; font-size:7px">Yamaguchi, </span><span style="font-family: Courier; font-size:8px">Enjoji
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:156px; top:2068px; width:170px; height:27px;"><span style="font-family: Courier; font-size:8px">Figure </span><span style="font-family: Courier; font-size:7px">6: </span><span style="font-family: Courier; font-size:8px">Atypical </span><span style="font-family: Courier; font-size:7px">tubules </span><span style="font-family: Courier; font-size:6px">are </span><span style="font-family: Courier; font-size:7px">lined </span><span style="font-family: Courier; font-size:8px">by </span><span style="font-family: Courier; font-size:7px">columnar cells
<br></span><span style="font-family: Courier; font-size:7px">containing </span><span style="font-family: Courier; font-size:7px">Paneth </span><span style="font-family: Courier; font-size:7px">granules. </span><span style="font-family: Courier; font-size:7px">(Haematoxylin </span><span style="font-family: Courier; font-size:7px">and </span><span style="font-family: Courier; font-size:8px">eosin,
<br></span><span style="font-family: Courier; font-size:7px">original </span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:7px">x </span><span style="font-family: Courier; font-size:7px">600.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:361px; top:2069px; width:192px; height:27px;"><span style="font-family: Courier; font-size:8px">Figure </span><span style="font-family: Courier; font-size:7px">10: </span><span style="font-family: Courier; font-size:7px">CA19-9 </span><span style="font-family: Courier; font-size:7px">immunoreactants </span><span style="font-family: Courier; font-size:6px">are </span><span style="font-family: Courier; font-size:6px">seen </span><span style="font-family: Courier; font-size:8px">diffusely </span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:7px">the
<br></span><span style="font-family: Courier; font-size:7px">cytoplasm </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">adenoma </span><span style="font-family: Courier; font-size:7px">cells. </span><span style="font-family: Courier; font-size:7px">(ABC </span><span style="font-family: Courier; font-size:7px">method, </span><span style="font-family: Courier; font-size:7px">original
<br></span><span style="font-family: Courier; font-size:8px">magnification </span><span style="font-family: Courier; font-size:8px">x240.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:486px; top:2127px; width:27px; height:13px;"><span style="font-family: Courier; font-size:9px">mainly
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:524px; top:2127px; width:7px; height:12px;"><span style="font-family: Courier; font-size:8px">in
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:419px; top:2127px; width:56px; height:13px;"><span style="font-family: Courier; font-size:9px">intraluminally
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:361px; top:2116px; width:193px; height:159px;"><span style="font-family: Courier; font-size:8px">in all </span><span style="font-family: Courier; font-size:7px">cases. </span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:7px">seven </span><span style="font-family: Courier; font-size:8px">tumours, </span><span style="font-family: Courier; font-size:9px">atypical </span><span style="font-family: Courier; font-size:9px">epithelia
<br></span><span style="font-family: Courier; font-size:9px">proliferated
<br></span><span style="font-family: Courier; font-size:8px">the
<br></span><span style="font-family: Courier; font-size:7px">common </span><span style="font-family: Courier; font-size:8px">channel </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">intraduodenal </span><span style="font-family: Courier; font-size:8px">bile </span><span style="font-family: Courier; font-size:9px">duct,
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:9px">focally </span><span style="font-family: Courier; font-size:8px">in the </span><span style="font-family: Courier; font-size:8px">intraduodenal </span><span style="font-family: Courier; font-size:9px">pancreatic </span><span style="font-family: Courier; font-size:8px">duct.
<br></span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:8px">the other five </span><span style="font-family: Courier; font-size:8px">tumours, </span><span style="font-family: Courier; font-size:8px">tumour </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:9px">exophyti-
<br></span><span style="font-family: Courier; font-size:9px">cally </span><span style="font-family: Courier; font-size:9px">proliferated </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">extended </span><span style="font-family: Courier; font-size:8px">onto </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">duo-
<br>denal </span><span style="font-family: Courier; font-size:8px">mucosa, </span><span style="font-family: Courier; font-size:9px">forming </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:9px">polyp </span><span style="font-family: Courier; font-size:8px">surrounding </span><span style="font-family: Courier; font-size:8px">the
<br></span><span style="font-family: Courier; font-size:8px">orifices </span><span style="font-family: Courier; font-size:8px">of the </span><span style="font-family: Courier; font-size:8px">main </span><span style="font-family: Courier; font-size:8px">pancreatic </span><span style="font-family: Courier; font-size:8px">duct, </span><span style="font-family: Courier; font-size:8px">and the
<br></span><span style="font-family: Courier; font-size:8px">common </span><span style="font-family: Courier; font-size:8px">bile </span><span style="font-family: Courier; font-size:8px">duct </span><span style="font-family: Courier; font-size:8px">drained </span><span style="font-family: Courier; font-size:8px">into the </span><span style="font-family: Courier; font-size:8px">polyps. </span><span style="font-family: Courier; font-size:8px">In
<br></span><span style="font-family: Courier; font-size:8px">four </span><span style="font-family: Courier; font-size:9px">large </span><span style="font-family: Courier; font-size:8px">tumours, there </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">foci </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">epithelia </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">moderate </span><span style="font-family: Courier; font-size:8px">dysplasia </span><span style="font-family: Courier; font-size:8px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">deep </span><span style="font-family: Courier; font-size:8px">portions </span><span style="font-family: Courier; font-size:8px">(Fig </span><span style="font-family: Courier; font-size:9px">7)
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">another </span><span style="font-family: Courier; font-size:9px">larger </span><span style="font-family: Courier; font-size:9px">adenoma, </span><span style="font-family: Courier; font-size:8px">severe </span><span style="font-family: Courier; font-size:9px">dysplasia
<br></span><span style="font-family: Courier; font-size:9px">(intramucosal </span><span style="font-family: Courier; font-size:9px">carcinoma) </span><span style="font-family: Courier; font-size:8px">was </span><span style="font-family: Courier; font-size:8px">encountered </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:7px">a
<br></span><span style="font-family: Courier; font-size:8px">tubular </span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:9px">(Fig 8) </span><span style="font-family: Courier; font-size:8px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">orifice of </span><span style="font-family: Courier; font-size:9px">ampulla
<br></span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:361px; top:2298px; width:194px; height:209px;"><span style="font-family: Courier; font-size:6px">HISTOCHEMICAL </span><span style="font-family: Courier; font-size:6px">AND </span><span style="font-family: Courier; font-size:6px">IMMUNOHISTOCHEMICAL
<br></span><span style="font-family: Courier; font-size:6px">STUDIES
<br></span><span style="font-family: Courier; font-size:9px">Cytoplasm </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">tumour </span><span style="font-family: Courier; font-size:8px">cells with </span><span style="font-family: Courier; font-size:8px">goblet </span><span style="font-family: Courier; font-size:8px">cell
<br></span><span style="font-family: Courier; font-size:8px">differentiation </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">positive </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">periodic </span><span style="font-family: Courier; font-size:8px">acid
<br>Schiff </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">alcian blue. The </span><span style="font-family: Courier; font-size:8px">incomplete </span><span style="font-family: Courier; font-size:8px">or </span><span style="font-family: Courier; font-size:8px">com-
<br></span><span style="font-family: Courier; font-size:9px">plete </span><span style="font-family: Courier; font-size:8px">brush </span><span style="font-family: Courier; font-size:8px">borders </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">positive </span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:9px">periodic
<br></span><span style="font-family: Courier; font-size:8px">acid Schiff </span><span style="font-family: Courier; font-size:8px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">luminal </span><span style="font-family: Courier; font-size:8px">surface. </span><span style="font-family: Courier; font-size:8px">Grimelius'
<br></span><span style="font-family: Courier; font-size:9px">positive </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">scattered </span><span style="font-family: Courier; font-size:8px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">basal </span><span style="font-family: Courier; font-size:8px">layer </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">atypical </span><span style="font-family: Courier; font-size:8px">tubules </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">11 </span><span style="font-family: Courier; font-size:8px">cases. </span><span style="font-family: Courier; font-size:8px">The normal </span><span style="font-family: Courier; font-size:8px">duodenal
<br></span><span style="font-family: Courier; font-size:9px">epithelia </span><span style="font-family: Courier; font-size:8px">had </span><span style="font-family: Courier; font-size:8px">linear </span><span style="font-family: Courier; font-size:8px">immunoreactants </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">CEA
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA19-9 </span><span style="font-family: Courier; font-size:8px">at </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">apical </span><span style="font-family: Courier; font-size:8px">portions. Paneth </span><span style="font-family: Courier; font-size:9px">cells,
<br></span><span style="font-family: Courier; font-size:8px">argentaffin cells and </span><span style="font-family: Courier; font-size:8px">goblet </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">negative
<br></span><span style="font-family: Courier; font-size:8px">for </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA19-9. </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and CA </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:8px">im-
<br></span><span style="font-family: Courier; font-size:8px">munoreactants </span><span style="font-family: Courier; font-size:8px">were present </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">line </span><span style="font-family: Courier; font-size:8px">along </span><span style="font-family: Courier; font-size:8px">the
<br></span><span style="font-family: Courier; font-size:8px">luminal surface while </span><span style="font-family: Courier; font-size:8px">they </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">only </span><span style="font-family: Courier; font-size:8px">weakly
<br></span><span style="font-family: Courier; font-size:8px">observed </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">cytoplasms </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">adenoma of </span><span style="font-family: Courier; font-size:8px">mild </span><span style="font-family: Courier; font-size:8px">to
<br></span><span style="font-family: Courier; font-size:8px">moderate </span><span style="font-family: Courier; font-size:8px">cellular </span><span style="font-family: Courier; font-size:8px">atypia (Fig 9). </span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">severe </span><span style="font-family: Courier; font-size:8px">dysplasia </span><span style="font-family: Courier; font-size:8px">(intramucosal carcinoma), </span><span style="font-family: Courier; font-size:8px">CEA
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:8px">immunoreactants </span><span style="font-family: Courier; font-size:8px">were present more
<br></span><span style="font-family: Courier; font-size:8px">densely </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">diffusely </span><span style="font-family: Courier; font-size:8px">in the cytoplasms (Fig </span><span style="font-family: Courier; font-size:8px">10).
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:360px; top:2528px; width:192px; height:51px;"><span style="font-family: Courier; font-size:6px">PROGNOSIS
<br></span><span style="font-family: Courier; font-size:8px">Ten </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the 12 </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">were well </span><span style="font-family: Courier; font-size:8px">from </span><span style="font-family: Courier; font-size:8px">2 </span><span style="font-family: Courier; font-size:8px">months </span><span style="font-family: Courier; font-size:8px">to
<br></span><span style="font-family: Courier; font-size:8px">96 </span><span style="font-family: Courier; font-size:8px">months after </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">operation. Two </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">died
<br></span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">cardiac </span><span style="font-family: Courier; font-size:8px">failure </span><span style="font-family: Courier; font-size:8px">17 </span><span style="font-family: Courier; font-size:8px">months </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">21 </span><span style="font-family: Courier; font-size:8px">months </span><span style="font-family: Courier; font-size:8px">after
<br></span><span style="font-family: Courier; font-size:8px">surgery, </span><span style="font-family: Courier; font-size:8px">but </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">free </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">any </span><span style="font-family: Courier; font-size:8px">metastasis.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:360px; top:2598px; width:192px; height:43px;"><span style="font-family: Courier; font-size:8px">Discussion
<br></span><span style="font-family: Courier; font-size:8px">Adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">is </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">rare
<br></span><span style="font-family: Courier; font-size:8px">neoplasm </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">an </span><span style="font-family: Courier; font-size:8px">incidence </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">0 </span><span style="font-family: Courier; font-size:8px">04 </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">0 </span><span style="font-family: Courier; font-size:8px">12% </span><span style="font-family: Courier; font-size:8px">in
<br></span><span style="font-family: Courier; font-size:8px">postmortem </span><span style="font-family: Courier; font-size:8px">series,' </span><span style="font-family: Courier; font-size:8px">4and </span><span style="font-family: Courier; font-size:8px">several </span><span style="font-family: Courier; font-size:8px">different </span><span style="font-family: Courier; font-size:8px">terms
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:53px; top:2234px; width:90px; height:42px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">7: </span><span style="font-family: Courier; font-size:7px">Foci </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">moderate
<br></span><span style="font-family: Courier; font-size:7px">dysplasia </span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:7px">adenoma </span><span style="font-family: Courier; font-size:7px">of</span><span style="font-family: Courier; font-size:7px">mild
<br></span><span style="font-family: Courier; font-size:7px">dysplasia. </span><span style="font-family: Courier; font-size:7px">(Haematoxylin
<br></span><span style="font-family: Courier; font-size:7px">and </span><span style="font-family: Courier; font-size:7px">eosin, </span><span style="font-family: Courier; font-size:7px">original
<br></span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:5px">x </span><span style="font-family: Courier; font-size:7px">77.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:53px; top:2409px; width:80px; height:51px;"><span style="font-family: Courier; font-size:7px">Figure </span><span style="font-family: Courier; font-size:7px">8: </span><span style="font-family: Courier; font-size:7px">Foci </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:5px">severe
<br></span><span style="font-family: Courier; font-size:7px">dysplasia </span><span style="font-family: Courier; font-size:7px">(intramucosal
<br></span><span style="font-family: Courier; font-size:7px">carcinoma) </span><span style="font-family: Courier; font-size:7px">in </span><span style="font-family: Courier; font-size:7px">tubular
<br></span><span style="font-family: Courier; font-size:7px">adenoma. </span><span style="font-family: Courier; font-size:7px">(Haematoxylin
<br></span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:7px">eosin, </span><span style="font-family: Courier; font-size:7px">original
<br></span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:3px">x </span><span style="font-family: Courier; font-size:7px">102.)
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:51px; top:2589px; width:88px; height:49px;"><span style="font-family: Courier; font-size:5px">Figure </span><span style="font-family: Courier; font-size:7px">9: </span><span style="font-family: Courier; font-size:7px">CEA
<br></span><span style="font-family: Courier; font-size:5px">immunoreactants </span><span style="font-family: Courier; font-size:4px">are </span><span style="font-family: Courier; font-size:5px">present
<br></span><span style="font-family: Courier; font-size:6px">in </span><span style="font-family: Courier; font-size:4px">a </span><span style="font-family: Courier; font-size:7px">linear </span><span style="font-family: Courier; font-size:5px">at </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:7px">apical
<br></span><span style="font-family: Courier; font-size:7px">portion </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">adenoma </span><span style="font-family: Courier; font-size:6px">cells.
<br></span><span style="font-family: Courier; font-size:7px">(ABC </span><span style="font-family: Courier; font-size:7px">method, original
<br></span><span style="font-family: Courier; font-size:7px">magnification </span><span style="font-family: Courier; font-size:5px">x </span><span style="font-family: Courier; font-size:7px">115.)
<br></span></div><span style="position:absolute; border: gray 1px solid; left:0px; top:2734px; width:595px; height:844px;"></span>
<div style="position:absolute; top:2734px;"><a name="4">Page 4</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:44px; top:2782px; width:190px; height:11px;"><span style="font-family: Courier; font-size:7px">Adenoma </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">the </span><span style="font-family: Courier; font-size:7px">ampulla </span><span style="font-family: Courier; font-size:7px">of </span><span style="font-family: Courier; font-size:7px">Vater: </span><span style="font-family: Courier; font-size:7px">putative precancerous </span><span style="font-family: Courier; font-size:7px">lesion
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:527px; top:2781px; width:14px; height:10px;"><span style="font-family: Courier; font-size:7px">1561
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:147px; top:2807px; width:191px; height:141px;"><span style="font-family: Courier; font-size:8px">have been </span><span style="font-family: Courier; font-size:8px">applied </span><span style="font-family: Courier; font-size:8px">to </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">probable </span><span style="font-family: Courier; font-size:8px">adenoma,
<br></span><span style="font-family: Courier; font-size:8px">including </span><span style="font-family: Courier; font-size:8px">polyp, </span><span style="font-family: Courier; font-size:8px">papilloma3 </span><span style="font-family: Courier; font-size:8px">and adenomatous
<br>polyp.8 </span><span style="font-family: Courier; font-size:8px">Icterus </span><span style="font-family: Courier; font-size:8px">has been observed in </span><span style="font-family: Courier; font-size:8px">69-2 </span><span style="font-family: Courier; font-size:8px">to
<br></span><span style="font-family: Courier; font-size:8px">100% of </span><span style="font-family: Courier; font-size:8px">patients </span><span style="font-family: Courier; font-size:8px">with </span><span style="font-family: Courier; font-size:8px">carcinoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla
<br></span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">and a </span><span style="font-family: Courier; font-size:8px">fluctuation of jaundice </span><span style="font-family: Courier; font-size:8px">is </span><span style="font-family: Courier; font-size:8px">charac-
<br></span><span style="font-family: Courier; font-size:8px">teristic of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">carcinoma.46 </span><span style="font-family: Courier; font-size:8px">On the other </span><span style="font-family: Courier; font-size:8px">hand, the
<br></span><span style="font-family: Courier; font-size:8px">clinical </span><span style="font-family: Courier; font-size:8px">aspects </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">have </span><span style="font-family: Courier; font-size:8px">not yet
<br></span><span style="font-family: Courier; font-size:8px">been described </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">large </span><span style="font-family: Courier; font-size:8px">series. </span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">present
<br></span><span style="font-family: Courier; font-size:9px">study of </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">cases </span><span style="font-family: Courier; font-size:9px">of </span><span style="font-family: Courier; font-size:8px">adenoma, only </span><span style="font-family: Courier; font-size:8px">three </span><span style="font-family: Courier; font-size:8px">patients
<br></span><span style="font-family: Courier; font-size:9px">developed </span><span style="font-family: Courier; font-size:8px">icterus </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">none </span><span style="font-family: Courier; font-size:8px">had </span><span style="font-family: Courier; font-size:8px">any </span><span style="font-family: Courier; font-size:8px">fluctuation
<br></span><span style="font-family: Courier; font-size:8px">of icterus. </span><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:9px">difference </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:9px">frequency </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">icterus
<br></span><span style="font-family: Courier; font-size:8px">may </span><span style="font-family: Courier; font-size:8px">be due </span><span style="font-family: Courier; font-size:8px">to </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">slow </span><span style="font-family: Courier; font-size:9px">growing </span><span style="font-family: Courier; font-size:8px">nature </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla of </span><span style="font-family: Courier; font-size:8px">Vater.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:147px; top:2946px; width:191px; height:108px;"><span style="font-family: Courier; font-size:8px">Tasaka9 </span><span style="font-family: Courier; font-size:8px">reported </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">histological </span><span style="font-family: Courier; font-size:8px">examination </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:8px">normal ampulla of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">and said that </span><span style="font-family: Courier; font-size:8px">goblet,
<br></span><span style="font-family: Courier; font-size:8px">Paneth </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">argentaffin </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">were seen </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">72 -6%,
<br></span><span style="font-family: Courier; font-size:8px">11 </span><span style="font-family: Courier; font-size:8px">0% </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">93 </span><span style="font-family: Courier; font-size:8px">3%, </span><span style="font-family: Courier; font-size:8px">respectively, of </span><span style="font-family: Courier; font-size:8px">the ampulla </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">73 </span><span style="font-family: Courier; font-size:8px">cases </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">autopsy </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">surgical </span><span style="font-family: Courier; font-size:8px">material.
<br></span><span style="font-family: Courier; font-size:8px">In </span><span style="font-family: Courier; font-size:8px">the present </span><span style="font-family: Courier; font-size:8px">study </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">12 </span><span style="font-family: Courier; font-size:8px">adenoma cases, </span><span style="font-family: Courier; font-size:8px">goblet
<br></span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:9px">found </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">12, </span><span style="font-family: Courier; font-size:9px">argentaffin </span><span style="font-family: Courier; font-size:8px">cells in </span><span style="font-family: Courier; font-size:8px">11 </span><span style="font-family: Courier; font-size:8px">and
<br>Paneth </span><span style="font-family: Courier; font-size:8px">cells </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">encountered in eight. </span><span style="font-family: Courier; font-size:8px">Most </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">the adenomas </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater </span><span style="font-family: Courier; font-size:8px">showed
<br></span><span style="font-family: Courier; font-size:8px">differentiation into intestinal epithelia.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:147px; top:3052px; width:191px; height:140px;"><span style="font-family: Courier; font-size:8px">The adenoma-carcinoma </span><span style="font-family: Courier; font-size:8px">sequence </span><span style="font-family: Courier; font-size:8px">is generally
<br></span><span style="font-family: Courier; font-size:8px">accepted </span><span style="font-family: Courier; font-size:8px">in adenomas </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the colon </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">rectum,&quot;&quot;'3
<br></span><span style="font-family: Courier; font-size:8px">the basic evidence being </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">coexistence </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">carcinoma in the </span><span style="font-family: Courier; font-size:8px">same </span><span style="font-family: Courier; font-size:8px">lesion. </span><span style="font-family: Courier; font-size:8px">In
<br></span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">Vater, the </span><span style="font-family: Courier; font-size:8px">foci </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">situ
<br></span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">invasive carcinoma </span><span style="font-family: Courier; font-size:8px">were </span><span style="font-family: Courier; font-size:8px">found </span><span style="font-family: Courier; font-size:8px">in the
<br></span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">lesion.14 </span><span style="font-family: Courier; font-size:8px">5 </span><span style="font-family: Courier; font-size:8px">On the other hand, </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">our
<br></span><span style="font-family: Courier; font-size:8px">previous </span><span style="font-family: Courier; font-size:8px">study </span><span style="font-family: Courier; font-size:8px">residual adenoma </span><span style="font-family: Courier; font-size:8px">was </span><span style="font-family: Courier; font-size:8px">present at
<br></span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:9px">periphery </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">carcinoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">ampulla </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">Vater in </span><span style="font-family: Courier; font-size:8px">20 </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">109 </span><span style="font-family: Courier; font-size:9px">cases,4 </span><span style="font-family: Courier; font-size:8px">and the reported </span><span style="font-family: Courier; font-size:8px">rate
<br></span><span style="font-family: Courier; font-size:8px">was 20 to </span><span style="font-family: Courier; font-size:8px">82%.'121 </span><span style="font-family: Courier; font-size:8px">Such </span><span style="font-family: Courier; font-size:8px">evidence </span><span style="font-family: Courier; font-size:8px">supports </span><span style="font-family: Courier; font-size:8px">the
<br></span><span style="font-family: Courier; font-size:8px">adenoma-carcinoma </span><span style="font-family: Courier; font-size:8px">sequence </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the ampulla </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">Vater.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:148px; top:3190px; width:191px; height:235px;"><span style="font-family: Courier; font-size:8px">The </span><span style="font-family: Courier; font-size:8px">presence </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:8px">colonic </span><span style="font-family: Courier; font-size:8px">adenomas </span><span style="font-family: Courier; font-size:8px">has
<br>been demonstrated </span><span style="font-family: Courier; font-size:8px">by </span><span style="font-family: Courier; font-size:8px">several authors.2223 </span><span style="font-family: Courier; font-size:8px">The
<br></span><span style="font-family: Courier; font-size:8px">patterns </span><span style="font-family: Courier; font-size:8px">of CEA </span><span style="font-family: Courier; font-size:8px">distribution </span><span style="font-family: Courier; font-size:8px">are </span><span style="font-family: Courier; font-size:8px">similar </span><span style="font-family: Courier; font-size:8px">to </span><span style="font-family: Courier; font-size:8px">those
<br></span><span style="font-family: Courier; font-size:8px">in </span><span style="font-family: Courier; font-size:9px">ampullary adenomas, </span><span style="font-family: Courier; font-size:8px">with moderate </span><span style="font-family: Courier; font-size:9px">staining
<br></span><span style="font-family: Courier; font-size:8px">along </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">glycocalyceal </span><span style="font-family: Courier; font-size:8px">borders </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:9px">faint </span><span style="font-family: Courier; font-size:8px">cyto-
<br></span><span style="font-family: Courier; font-size:8px">plasmic </span><span style="font-family: Courier; font-size:8px">staining of </span><span style="font-family: Courier; font-size:9px">neoplastic </span><span style="font-family: Courier; font-size:8px">cells.22 Isaacson
<br>and </span><span style="font-family: Courier; font-size:8px">LeVann23 </span><span style="font-family: Courier; font-size:9px">suggested </span><span style="font-family: Courier; font-size:8px">that CEA </span><span style="font-family: Courier; font-size:9px">might </span><span style="font-family: Courier; font-size:8px">be </span><span style="font-family: Courier; font-size:8px">a
<br></span><span style="font-family: Courier; font-size:8px">reliable </span><span style="font-family: Courier; font-size:8px">indicator </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:9px">malignant </span><span style="font-family: Courier; font-size:8px">change </span><span style="font-family: Courier; font-size:8px">within
<br>colonic </span><span style="font-family: Courier; font-size:8px">adenoma. </span><span style="font-family: Courier; font-size:8px">Our </span><span style="font-family: Courier; font-size:8px">results of </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and
<br></span><span style="font-family: Courier; font-size:8px">CA19-9 </span><span style="font-family: Courier; font-size:9px">staining </span><span style="font-family: Courier; font-size:8px">in adenoma </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:9px">ampulla </span><span style="font-family: Courier; font-size:8px">of
<br>Vater </span><span style="font-family: Courier; font-size:8px">was </span><span style="font-family: Courier; font-size:8px">almost </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">same as </span><span style="font-family: Courier; font-size:8px">those </span><span style="font-family: Courier; font-size:8px">of colonic
<br></span><span style="font-family: Courier; font-size:8px">adenoma. </span><span style="font-family: Courier; font-size:9px">Ampullary </span><span style="font-family: Courier; font-size:8px">adenoma with </span><span style="font-family: Courier; font-size:8px">severe </span><span style="font-family: Courier; font-size:9px">atypia
<br></span><span style="font-family: Courier; font-size:9px">(intramucosal </span><span style="font-family: Courier; font-size:9px">carcinoma) </span><span style="font-family: Courier; font-size:8px">showed </span><span style="font-family: Courier; font-size:8px">a </span><span style="font-family: Courier; font-size:9px">staining
<br></span><span style="font-family: Courier; font-size:8px">similar </span><span style="font-family: Courier; font-size:8px">to, </span><span style="font-family: Courier; font-size:8px">but </span><span style="font-family: Courier; font-size:8px">more </span><span style="font-family: Courier; font-size:8px">intense </span><span style="font-family: Courier; font-size:9px">than, </span><span style="font-family: Courier; font-size:8px">that </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the
<br></span><span style="font-family: Courier; font-size:8px">associated </span><span style="font-family: Courier; font-size:8px">adenomas of </span><span style="font-family: Courier; font-size:8px">moderate </span><span style="font-family: Courier; font-size:9px">dysplasia. </span><span style="font-family: Courier; font-size:8px">The
<br></span><span style="font-family: Courier; font-size:9px">staining </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">CEA </span><span style="font-family: Courier; font-size:8px">and CA </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:9px">appeared </span><span style="font-family: Courier; font-size:8px">repre-
<br></span><span style="font-family: Courier; font-size:8px">sentative </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:9px">degree </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:9px">dysplasia </span><span style="font-family: Courier; font-size:8px">in the
<br></span><span style="font-family: Courier; font-size:9px">relationship
<br></span><span style="font-family: Courier; font-size:8px">adenoma </span><span style="font-family: Courier; font-size:8px">cells.
<br></span><span style="font-family: Courier; font-size:8px">between </span><span style="font-family: Courier; font-size:8px">staining </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">the </span><span style="font-family: Courier; font-size:8px">degree </span><span style="font-family: Courier; font-size:8px">of </span><span style="font-family: Courier; font-size:9px">dysplasia </span><span style="font-family: Courier; font-size:8px">was
<br></span><span style="font-family: Courier; font-size:8px">not </span><span style="font-family: Courier; font-size:8px">conclusive. These </span><span style="font-family: Courier; font-size:8px">differences </span><span style="font-family: Courier; font-size:8px">in immuno-
<br></span><span style="font-family: Courier; font-size:8px">reactivity </span><span style="font-family: Courier; font-size:8px">for CEA </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">CA </span><span style="font-family: Courier; font-size:8px">19-9 </span><span style="font-family: Courier; font-size:8px">may </span><span style="font-family: Courier; font-size:8px">be </span><span style="font-family: Courier; font-size:8px">of
<br></span><span style="font-family: Courier; font-size:8px">diagnostic </span><span style="font-family: Courier; font-size:8px">value in </span><span style="font-family: Courier; font-size:9px">discriminating </span><span style="font-family: Courier; font-size:8px">among </span><span style="font-family: Courier; font-size:8px">the
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:222px; top:3371px; width:38px; height:12px;"><span style="font-family: Courier; font-size:8px">However,
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:350px; top:2807px; width:191px; height:23px;"><span style="font-family: Courier; font-size:8px">different </span><span style="font-family: Courier; font-size:8px">adenoma cells </span><span style="font-family: Courier; font-size:8px">of moderate and </span><span style="font-family: Courier; font-size:8px">severe
<br></span><span style="font-family: Courier; font-size:8px">dysplasia </span><span style="font-family: Courier; font-size:8px">and </span><span style="font-family: Courier; font-size:8px">early </span><span style="font-family: Courier; font-size:8px">invasive carcinoma.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:350px; top:2844px; width:192px; height:88px;"><span style="font-family: Courier; font-size:6px">We </span><span style="font-family: Courier; font-size:6px">thank the </span><span style="font-family: Courier; font-size:6px">surgical </span><span style="font-family: Courier; font-size:6px">staff of the following eight hospitals for
<br></span><span style="font-family: Courier; font-size:6px">providing the </span><span style="font-family: Courier; font-size:6px">surgical material: </span><span style="font-family: Courier; font-size:6px">First Department </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Surgery,
<br></span><span style="font-family: Courier; font-size:6px">Faculty </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Medicine, Kyushu </span><span style="font-family: Courier; font-size:6px">University; </span><span style="font-family: Courier; font-size:6px">First </span><span style="font-family: Courier; font-size:6px">Department </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:6px">Surgery, </span><span style="font-family: Courier; font-size:6px">School </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Medicine, </span><span style="font-family: Courier; font-size:6px">Fukuoka </span><span style="font-family: Courier; font-size:6px">University; </span><span style="font-family: Courier; font-size:6px">National
<br></span><span style="font-family: Courier; font-size:6px">Kokura </span><span style="font-family: Courier; font-size:6px">Hospital; </span><span style="font-family: Courier; font-size:6px">National </span><span style="font-family: Courier; font-size:6px">Tagawa </span><span style="font-family: Courier; font-size:6px">Shinsei </span><span style="font-family: Courier; font-size:7px">Hospital; </span><span style="font-family: Courier; font-size:6px">Prefectural
<br></span><span style="font-family: Courier; font-size:6px">Ehime </span><span style="font-family: Courier; font-size:6px">Central </span><span style="font-family: Courier; font-size:6px">Hospital; </span><span style="font-family: Courier; font-size:6px">Kitakyushu Wakamatsu </span><span style="font-family: Courier; font-size:6px">Hospital;
<br></span><span style="font-family: Courier; font-size:6px">Matsuyama </span><span style="font-family: Courier; font-size:6px">Red Cross </span><span style="font-family: Courier; font-size:7px">Hospital; </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">Hofu </span><span style="font-family: Courier; font-size:6px">Gastrointestinal </span><span style="font-family: Courier; font-size:6px">Hos-
<br></span><span style="font-family: Courier; font-size:6px">pital. We thank Mr Brian </span><span style="font-family: Courier; font-size:6px">T </span><span style="font-family: Courier; font-size:6px">Quinn </span><span style="font-family: Courier; font-size:6px">for </span><span style="font-family: Courier; font-size:6px">critical </span><span style="font-family: Courier; font-size:6px">comments on </span><span style="font-family: Courier; font-size:6px">this
<br></span><span style="font-family: Courier; font-size:6px">manuscript. </span><span style="font-family: Courier; font-size:6px">This </span><span style="font-family: Courier; font-size:6px">study </span><span style="font-family: Courier; font-size:6px">was </span><span style="font-family: Courier; font-size:6px">in </span><span style="font-family: Courier; font-size:6px">part </span><span style="font-family: Courier; font-size:6px">supported by </span><span style="font-family: Courier; font-size:6px">a </span><span style="font-family: Courier; font-size:6px">Grant-in-Aid
<br>from </span><span style="font-family: Courier; font-size:6px">the Ministry </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Health and </span><span style="font-family: Courier; font-size:6px">Welfare for </span><span style="font-family: Courier; font-size:6px">Comprehensive </span><span style="font-family: Courier; font-size:6px">10-
<br></span><span style="font-family: Courier; font-size:6px">year </span><span style="font-family: Courier; font-size:6px">Strategy </span><span style="font-family: Courier; font-size:6px">for </span><span style="font-family: Courier; font-size:6px">Cancer Control, Japan, </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">by </span><span style="font-family: Courier; font-size:6px">a </span><span style="font-family: Courier; font-size:6px">grant </span><span style="font-family: Courier; font-size:6px">from
<br></span><span style="font-family: Courier; font-size:6px">Fukuoka </span><span style="font-family: Courier; font-size:6px">Cancer </span><span style="font-family: Courier; font-size:6px">Society.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:2947px; width:191px; height:378px;"><span style="font-family: Courier; font-size:6px">1 </span><span style="font-family: Courier; font-size:6px">Baggenstoss </span><span style="font-family: Courier; font-size:6px">AH. </span><span style="font-family: Courier; font-size:6px">Major </span><span style="font-family: Courier; font-size:6px">duodenal papilla. </span><span style="font-family: Courier; font-size:6px">Variations </span><span style="font-family: Courier; font-size:6px">of patho-
<br></span><span style="font-family: Courier; font-size:6px">logic </span><span style="font-family: Courier; font-size:6px">interest and lesions </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">mucosa. </span><span style="font-family: Courier; font-size:6px">Arch Pathol </span><span style="font-family: Courier; font-size:6px">1938;
<br></span><span style="font-family: Courier; font-size:6px">26: </span><span style="font-family: Courier; font-size:6px">853-68.
<br></span><span style="font-family: Courier; font-size:6px">2 </span><span style="font-family: Courier; font-size:6px">Cattell RB, Pyrtek </span><span style="font-family: Courier; font-size:7px">LJ. </span><span style="font-family: Courier; font-size:6px">Premalignant </span><span style="font-family: Courier; font-size:6px">lesions of the </span><span style="font-family: Courier; font-size:6px">ampulla </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:6px">Vater. </span><span style="font-family: Courier; font-size:6px">Surg Gynecol </span><span style="font-family: Courier; font-size:6px">Obstet </span><span style="font-family: Courier; font-size:6px">1950; </span><span style="font-family: Courier; font-size:6px">90: 21-30.
<br>3 </span><span style="font-family: Courier; font-size:6px">Anderson </span><span style="font-family: Courier; font-size:6px">MC, Gregor </span><span style="font-family: Courier; font-size:6px">WH. </span><span style="font-family: Courier; font-size:6px">Papilloma of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">ampulla of
<br>Vater. </span><span style="font-family: Courier; font-size:7px">AmJ7 </span><span style="font-family: Courier; font-size:6px">Surg </span><span style="font-family: Courier; font-size:6px">1961; </span><span style="font-family: Courier; font-size:6px">10: </span><span style="font-family: Courier; font-size:6px">865-7 </span><span style="font-family: Courier; font-size:6px">1.
<br>4 </span><span style="font-family: Courier; font-size:6px">Yamaguchi K, </span><span style="font-family: Courier; font-size:6px">Enjoji </span><span style="font-family: Courier; font-size:6px">M. Carcinoma </span><span style="font-family: Courier; font-size:6px">of the </span><span style="font-family: Courier; font-size:6px">ampulla of </span><span style="font-family: Courier; font-size:6px">Vater. </span><span style="font-family: Courier; font-size:6px">A
<br></span><span style="font-family: Courier; font-size:6px">clinicopathologic study </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">pathologic </span><span style="font-family: Courier; font-size:6px">staging </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">109 </span><span style="font-family: Courier; font-size:6px">cases
<br></span><span style="font-family: Courier; font-size:6px">of carcinoma </span><span style="font-family: Courier; font-size:6px">and 5 </span><span style="font-family: Courier; font-size:6px">cases </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">adenoma. </span><span style="font-family: Courier; font-size:6px">Cancer </span><span style="font-family: Courier; font-size:6px">1987; </span><span style="font-family: Courier; font-size:6px">59:
<br></span><span style="font-family: Courier; font-size:6px">506-15.
<br></span><span style="font-family: Courier; font-size:6px">5 </span><span style="font-family: Courier; font-size:6px">Yamaguchi K, Enjoji </span><span style="font-family: Courier; font-size:6px">M. </span><span style="font-family: Courier; font-size:6px">Cystic </span><span style="font-family: Courier; font-size:6px">neoplasm </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">pancreas.
<br></span><span style="font-family: Courier; font-size:6px">Gastroenterology 1987; </span><span style="font-family: Courier; font-size:6px">92: </span><span style="font-family: Courier; font-size:6px">1934-43.
<br></span><span style="font-family: Courier; font-size:6px">6 </span><span style="font-family: Courier; font-size:6px">Yamaguchi K, Enjoji M, </span><span style="font-family: Courier; font-size:6px">Nakayama </span><span style="font-family: Courier; font-size:6px">N. </span><span style="font-family: Courier; font-size:6px">Extrahepatic </span><span style="font-family: Courier; font-size:6px">bile duct
<br></span><span style="font-family: Courier; font-size:6px">cancer. </span><span style="font-family: Courier; font-size:6px">A </span><span style="font-family: Courier; font-size:6px">clinicopathologic </span><span style="font-family: Courier; font-size:6px">study </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">immunohistochemistry
<br></span><span style="font-family: Courier; font-size:6px">for CEA, CA19-9 </span><span style="font-family: Courier; font-size:6px">and P21. </span><span style="font-family: Courier; font-size:6px">Worldj </span><span style="font-family: Courier; font-size:6px">Surg 1988; </span><span style="font-family: Courier; font-size:6px">12: </span><span style="font-family: Courier; font-size:6px">11-7.
<br></span><span style="font-family: Courier; font-size:6px">7 </span><span style="font-family: Courier; font-size:6px">Yamaguchi K, Enjoji </span><span style="font-family: Courier; font-size:6px">M. </span><span style="font-family: Courier; font-size:6px">Carcinoma </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">pancreas: </span><span style="font-family: Courier; font-size:6px">a
<br></span><span style="font-family: Courier; font-size:6px">clinicopathologic </span><span style="font-family: Courier; font-size:6px">study of </span><span style="font-family: Courier; font-size:6px">96 </span><span style="font-family: Courier; font-size:5px">cases </span><span style="font-family: Courier; font-size:6px">with </span><span style="font-family: Courier; font-size:6px">immunohisto-
<br>chemical observations. </span><span style="font-family: Courier; font-size:6px">J7pnJ7 </span><span style="font-family: Courier; font-size:6px">Clin </span><span style="font-family: Courier; font-size:6px">Oncol </span><span style="font-family: Courier; font-size:6px">1989; </span><span style="font-family: Courier; font-size:6px">19: 14-22.
<br>8 </span><span style="font-family: Courier; font-size:6px">Oh C, Jemerin </span><span style="font-family: Courier; font-size:6px">EE. </span><span style="font-family: Courier; font-size:6px">Benign adenomatous </span><span style="font-family: Courier; font-size:6px">polyps </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">papilla
<br></span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Vater. </span><span style="font-family: Courier; font-size:6px">Surgery </span><span style="font-family: Courier; font-size:6px">1965; </span><span style="font-family: Courier; font-size:6px">57: 495-503.
<br></span><span style="font-family: Courier; font-size:6px">9 </span><span style="font-family: Courier; font-size:6px">Tasaka K. Carcinoma in the </span><span style="font-family: Courier; font-size:6px">region </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the duodenal </span><span style="font-family: Courier; font-size:6px">papilla. </span><span style="font-family: Courier; font-size:6px">A
<br></span><span style="font-family: Courier; font-size:6px">histopathologic study. </span><span style="font-family: Courier; font-size:6px">Fukuoka </span><span style="font-family: Courier; font-size:6px">Acta </span><span style="font-family: Courier; font-size:6px">Med </span><span style="font-family: Courier; font-size:6px">1977; </span><span style="font-family: Courier; font-size:6px">68: </span><span style="font-family: Courier; font-size:6px">20-44.
<br>10 </span><span style="font-family: Courier; font-size:6px">Muto </span><span style="font-family: Courier; font-size:6px">T, Bussey HJR, </span><span style="font-family: Courier; font-size:6px">Morson </span><span style="font-family: Courier; font-size:6px">BC. </span><span style="font-family: Courier; font-size:6px">The evolution </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:5px">cancer </span><span style="font-family: Courier; font-size:6px">of
<br>the colon and </span><span style="font-family: Courier; font-size:5px">rectum. </span><span style="font-family: Courier; font-size:6px">Cancer </span><span style="font-family: Courier; font-size:6px">1975; </span><span style="font-family: Courier; font-size:6px">36: </span><span style="font-family: Courier; font-size:6px">2251-70.
<br></span><span style="font-family: Courier; font-size:6px">11 </span><span style="font-family: Courier; font-size:6px">Wolff </span><span style="font-family: Courier; font-size:6px">WI, </span><span style="font-family: Courier; font-size:6px">Shinya </span><span style="font-family: Courier; font-size:6px">H. </span><span style="font-family: Courier; font-size:6px">Definitive </span><span style="font-family: Courier; font-size:6px">treatment </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">'malignant'
<br></span><span style="font-family: Courier; font-size:6px">polyps </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the colon. </span><span style="font-family: Courier; font-size:6px">Ann </span><span style="font-family: Courier; font-size:6px">Surg </span><span style="font-family: Courier; font-size:6px">1975; </span><span style="font-family: Courier; font-size:6px">182: </span><span style="font-family: Courier; font-size:6px">516-25.
<br></span><span style="font-family: Courier; font-size:6px">12 Morson B. </span><span style="font-family: Courier; font-size:6px">The </span><span style="font-family: Courier; font-size:6px">polyp-cancer </span><span style="font-family: Courier; font-size:6px">sequence </span><span style="font-family: Courier; font-size:6px">in </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">large </span><span style="font-family: Courier; font-size:6px">bowel. </span><span style="font-family: Courier; font-size:6px">Proc
<br>R </span><span style="font-family: Courier; font-size:6px">Soc Med </span><span style="font-family: Courier; font-size:6px">1974; </span><span style="font-family: Courier; font-size:6px">67: </span><span style="font-family: Courier; font-size:6px">451-7.
<br></span><span style="font-family: Courier; font-size:6px">13 </span><span style="font-family: Courier; font-size:6px">Qizilbash </span><span style="font-family: Courier; font-size:6px">AH. </span><span style="font-family: Courier; font-size:6px">Pathologic </span><span style="font-family: Courier; font-size:6px">studies </span><span style="font-family: Courier; font-size:6px">in </span><span style="font-family: Courier; font-size:6px">colorectal </span><span style="font-family: Courier; font-size:6px">cancer. </span><span style="font-family: Courier; font-size:6px">A guide
<br></span><span style="font-family: Courier; font-size:6px">to </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">surgical pathology </span><span style="font-family: Courier; font-size:6px">examination </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">colorectal </span><span style="font-family: Courier; font-size:6px">speci-
<br></span><span style="font-family: Courier; font-size:5px">mens </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">review of features </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">prognostic significance.
<br></span><span style="font-family: Courier; font-size:6px">Pathol Ann </span><span style="font-family: Courier; font-size:6px">1985; </span><span style="font-family: Courier; font-size:6px">20: 1-46.
<br></span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">bile </span><span style="font-family: Courier; font-size:6px">ducts. N </span><span style="font-family: Courier; font-size:6px">EnglJ3 </span><span style="font-family: Courier; font-size:6px">Med </span><span style="font-family: Courier; font-size:6px">1962; </span><span style="font-family: Courier; font-size:6px">266: </span><span style="font-family: Courier; font-size:6px">57-61.
<br></span><span style="font-family: Courier; font-size:6px">15 </span><span style="font-family: Courier; font-size:6px">Sobol </span><span style="font-family: Courier; font-size:6px">S, </span><span style="font-family: Courier; font-size:6px">Cooperman </span><span style="font-family: Courier; font-size:6px">AM. </span><span style="font-family: Courier; font-size:6px">Villous adenoma of </span><span style="font-family: Courier; font-size:6px">the ampulla </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:6px">Vater. An unusual </span><span style="font-family: Courier; font-size:5px">cause </span><span style="font-family: Courier; font-size:6px">of biliary </span><span style="font-family: Courier; font-size:6px">colic </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">obstructive
<br></span><span style="font-family: Courier; font-size:6px">jaundice. </span><span style="font-family: Courier; font-size:6px">Gastroenterology </span><span style="font-family: Courier; font-size:6px">1978; </span><span style="font-family: Courier; font-size:6px">75: 107-9.
<br></span><span style="font-family: Courier; font-size:6px">16 </span><span style="font-family: Courier; font-size:6px">Baczako </span><span style="font-family: Courier; font-size:6px">K, </span><span style="font-family: Courier; font-size:6px">Buchler </span><span style="font-family: Courier; font-size:6px">M, Beger </span><span style="font-family: Courier; font-size:6px">HG, Kirkpatrick </span><span style="font-family: Courier; font-size:6px">J, </span><span style="font-family: Courier; font-size:6px">Haferkamp
<br></span><span style="font-family: Courier; font-size:6px">0. </span><span style="font-family: Courier; font-size:6px">Morphogenesis </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">possible </span><span style="font-family: Courier; font-size:6px">precursor </span><span style="font-family: Courier; font-size:6px">lesions </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">invasive
<br></span><span style="font-family: Courier; font-size:6px">carcinoma </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">papilla </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">Vater: </span><span style="font-family: Courier; font-size:6px">epithelial dysplasia </span><span style="font-family: Courier; font-size:6px">and
<br></span><span style="font-family: Courier; font-size:6px">adenoma. Hum Pathol </span><span style="font-family: Courier; font-size:6px">1985; </span><span style="font-family: Courier; font-size:6px">16: </span><span style="font-family: Courier; font-size:6px">305-10.
<br></span><span style="font-family: Courier; font-size:6px">17 </span><span style="font-family: Courier; font-size:6px">Kozuka S, </span><span style="font-family: Courier; font-size:6px">Tsubone </span><span style="font-family: Courier; font-size:6px">M, </span><span style="font-family: Courier; font-size:6px">Yamaguchi A, </span><span style="font-family: Courier; font-size:6px">Hachisuka K. Adeno-
<br></span><span style="font-family: Courier; font-size:6px">matous </span><span style="font-family: Courier; font-size:6px">residue in </span><span style="font-family: Courier; font-size:6px">cancerous </span><span style="font-family: Courier; font-size:6px">papilla </span><span style="font-family: Courier; font-size:6px">of Vater. </span><span style="font-family: Courier; font-size:6px">Gut </span><span style="font-family: Courier; font-size:6px">1981; </span><span style="font-family: Courier; font-size:6px">22:
<br>1031-4.
<br></span><span style="font-family: Courier; font-size:6px">18 </span><span style="font-family: Courier; font-size:6px">Perzin </span><span style="font-family: Courier; font-size:6px">KH, </span><span style="font-family: Courier; font-size:6px">Bridge </span><span style="font-family: Courier; font-size:6px">MF. Adenomas </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the small </span><span style="font-family: Courier; font-size:6px">intestine: </span><span style="font-family: Courier; font-size:6px">a
<br></span><span style="font-family: Courier; font-size:6px">clinicopathologic </span><span style="font-family: Courier; font-size:6px">review </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">51 </span><span style="font-family: Courier; font-size:6px">cases </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">a </span><span style="font-family: Courier; font-size:6px">study of </span><span style="font-family: Courier; font-size:6px">their
<br></span><span style="font-family: Courier; font-size:6px">relationship </span><span style="font-family: Courier; font-size:6px">to </span><span style="font-family: Courier; font-size:6px">carcinoma. Cancer </span><span style="font-family: Courier; font-size:6px">1981; </span><span style="font-family: Courier; font-size:6px">48: 799-819.
<br></span><span style="font-family: Courier; font-size:6px">19 </span><span style="font-family: Courier; font-size:6px">Buchler </span><span style="font-family: Courier; font-size:6px">M, </span><span style="font-family: Courier; font-size:6px">Rampf </span><span style="font-family: Courier; font-size:6px">W, </span><span style="font-family: Courier; font-size:6px">Baczako </span><span style="font-family: Courier; font-size:6px">K, </span><span style="font-family: Courier; font-size:6px">Lobeck </span><span style="font-family: Courier; font-size:6px">H, </span><span style="font-family: Courier; font-size:6px">Merkle </span><span style="font-family: Courier; font-size:7px">P,
<br></span><span style="font-family: Courier; font-size:6px">Bittner </span><span style="font-family: Courier; font-size:6px">R, </span><span style="font-family: Courier; font-size:5px">et </span><span style="font-family: Courier; font-size:6px">al. </span><span style="font-family: Courier; font-size:6px">Klinik </span><span style="font-family: Courier; font-size:6px">und Feinstruktur des </span><span style="font-family: Courier; font-size:6px">Papillen-
<br></span><span style="font-family: Courier; font-size:6px">karzinoms. Unter besonderer </span><span style="font-family: Courier; font-size:6px">Berucksichtigung </span><span style="font-family: Courier; font-size:6px">der </span><span style="font-family: Courier; font-size:6px">mor-
<br></span><span style="font-family: Courier; font-size:6px">phologischen Karzinogenese. </span><span style="font-family: Courier; font-size:6px">Dtsh Med Wochenschr </span><span style="font-family: Courier; font-size:6px">1984;
<br></span><span style="font-family: Courier; font-size:6px">109:1629-34.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:3182px; width:190px; height:9px;"><span style="font-family: Courier; font-size:6px">14 </span><span style="font-family: Courier; font-size:6px">Cattell RB, </span><span style="font-family: Courier; font-size:6px">Braasch </span><span style="font-family: Courier; font-size:6px">JW, </span><span style="font-family: Courier; font-size:6px">Kahn </span><span style="font-family: Courier; font-size:6px">F. </span><span style="font-family: Courier; font-size:6px">Polypoid epithelial </span><span style="font-family: Courier; font-size:6px">tumors
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:352px; top:3324px; width:191px; height:100px;"><span style="font-family: Courier; font-size:6px">20 </span><span style="font-family: Courier; font-size:6px">Blackman </span><span style="font-family: Courier; font-size:6px">E, </span><span style="font-family: Courier; font-size:6px">Nash </span><span style="font-family: Courier; font-size:6px">SV. </span><span style="font-family: Courier; font-size:6px">Diagnosis </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">duodenal and </span><span style="font-family: Courier; font-size:6px">ampullary
<br></span><span style="font-family: Courier; font-size:6px">epithelial neoplasms by </span><span style="font-family: Courier; font-size:6px">endoscopic biopsy:
<br></span><span style="font-family: Courier; font-size:5px">a </span><span style="font-family: Courier; font-size:6px">clinico-
<br></span><span style="font-family: Courier; font-size:6px">pathologic </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">immunohistochemical </span><span style="font-family: Courier; font-size:6px">study. </span><span style="font-family: Courier; font-size:6px">Hum </span><span style="font-family: Courier; font-size:6px">Pathol
<br></span><span style="font-family: Courier; font-size:6px">1985; </span><span style="font-family: Courier; font-size:6px">16:901-10.
<br></span><span style="font-family: Courier; font-size:6px">21 </span><span style="font-family: Courier; font-size:6px">Talbot </span><span style="font-family: Courier; font-size:6px">IC, Neoptolemos JP, </span><span style="font-family: Courier; font-size:6px">Shaw </span><span style="font-family: Courier; font-size:6px">DE, </span><span style="font-family: Courier; font-size:6px">Carr-Locke </span><span style="font-family: Courier; font-size:6px">D. </span><span style="font-family: Courier; font-size:6px">The
<br></span><span style="font-family: Courier; font-size:6px">histopathology </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">staging </span><span style="font-family: Courier; font-size:6px">of carcinoma </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">the </span><span style="font-family: Courier; font-size:6px">ampulla </span><span style="font-family: Courier; font-size:6px">of
<br></span><span style="font-family: Courier; font-size:6px">Vater. </span><span style="font-family: Courier; font-size:6px">Histopathology </span><span style="font-family: Courier; font-size:6px">1988; </span><span style="font-family: Courier; font-size:6px">12: </span><span style="font-family: Courier; font-size:6px">155-65.
<br></span><span style="font-family: Courier; font-size:6px">22 </span><span style="font-family: Courier; font-size:6px">Goldenberg DM, Sharkey </span><span style="font-family: Courier; font-size:6px">RM, </span><span style="font-family: Courier; font-size:6px">Primus </span><span style="font-family: Courier; font-size:6px">FJ. </span><span style="font-family: Courier; font-size:6px">Immunocyto-
<br></span><span style="font-family: Courier; font-size:6px">chemical detection </span><span style="font-family: Courier; font-size:6px">of </span><span style="font-family: Courier; font-size:6px">carcinoembryonic antigen </span><span style="font-family: Courier; font-size:6px">in </span><span style="font-family: Courier; font-size:5px">conven-
<br></span><span style="font-family: Courier; font-size:6px">tional </span><span style="font-family: Courier; font-size:6px">histopathology specimens. </span><span style="font-family: Courier; font-size:6px">Cancer 1978; </span><span style="font-family: Courier; font-size:6px">42: </span><span style="font-family: Courier; font-size:6px">1546-53.
<br></span><span style="font-family: Courier; font-size:6px">23 Isaacson </span><span style="font-family: Courier; font-size:6px">P, </span><span style="font-family: Courier; font-size:6px">LeVann HP. The demonstration of carcino-
<br></span><span style="font-family: Courier; font-size:6px">embryonic antigen </span><span style="font-family: Courier; font-size:6px">in colorectal </span><span style="font-family: Courier; font-size:6px">carcinoma </span><span style="font-family: Courier; font-size:6px">and </span><span style="font-family: Courier; font-size:6px">colonic
<br></span><span style="font-family: Courier; font-size:6px">polyps </span><span style="font-family: Courier; font-size:6px">using </span><span style="font-family: Courier; font-size:5px">an </span><span style="font-family: Courier; font-size:6px">immunoperoxidase </span><span style="font-family: Courier; font-size:6px">technique. </span><span style="font-family: Courier; font-size:6px">Cancer </span><span style="font-family: Courier; font-size:6px">1976;
<br></span><span style="font-family: Courier; font-size:6px">38: </span><span style="font-family: Courier; font-size:6px">1348-56.
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:270px; top:3371px; width:12px; height:12px;"><span style="font-family: Courier; font-size:8px">the
<br></span></div>